Driver mutations

References

• Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002; 2:897 - 909
   PubMed Web of Science ®Google Scholar
• Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4:437 - 450
   PubMed Web of Science ®Google Scholar
• Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J, et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 2003; 17:3112 - 3126
   PubMed Web of Science ®Google Scholar
• Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005; 7:469 - 483
   PubMed Web of Science ®Google Scholar
• Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 2006; 20:3130 - 3146
   PubMed Web of Science ®Google Scholar
• Carter HC, Samayoa J, Hruban RH, Karchin R. Prioritization of Driver Mutations in Pancreatic Cancer using Cancer-specific High-throughput Annotation of Somatic Mutations (CHASM). Cancer Biol Ther 2010; 10:582 - 587
   PubMed Web of Science ®Google Scholar
• Preis M, Korc M. Kinase signaling pathways as targets for intervention in pancreatic cancer. Cancer Biol Ther 2010; 9:754 - 763
   PubMed Web of Science ®Google Scholar
• Ramjaun AR, Downward J. Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis. Cell Cycle 2007; 6:2902 - 2905
   PubMed Web of Science ®Google Scholar
• Marone R, Cmiljanovic V, Giese B, Wymann MP. Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 2008; 1784:159 - 185
   PubMed Web of Science ®Google Scholar
• Wong KK, Engelman JA, Cantley LC. Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 2010; 20:87 - 90
   PubMed Web of Science ®Google Scholar
• Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, et al. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 1996; 93:3636 - 3641
   PubMed Web of Science ®Google Scholar
• Stanger BZ, Stiles B, Lauwers GY, Bardeesy N, Mendoza M, Wang Y, et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 2005; 8:185 - 195
   PubMed Web of Science ®Google Scholar
• Gukovsky I, Cheng JH, Nam KJ, Lee OT, Lugea A, Fischer L, et al. Phosphatidylinositide 3-kinase gamma regulates key pathologic responses to cholecystokinin in pancreatic acinar cells. Gastroenterology 2004; 126:554 - 566
   PubMed Web of Science ®Google Scholar
• Smith JP, Stanley WB, Verderame MF, Zagon IS. The functional significance of the cholecystokinin-C (CCK-C) receptor in human pancreatic cancer. Pancreas 2004; 29:271 - 277
   PubMed Web of Science ®Google Scholar
• Carriíre C, Young AL, Gunn JR, Longnecker DS, Korc M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem Biophys Res Commun 2009; 382:561 - 565
   PubMed Web of Science ®Google Scholar
• Kim MS, Rådinger M, Gilfillan AM. The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol 2008; 29:493 - 501
   PubMed Web of Science ®Google Scholar
• Esposito I, Kleeff J, Bischoff SC, Fischer L, Collecchi P, Iorio M, et al. The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Lab Invest 2002; 82:1481 - 1492
   PubMed Web of Science ®Google Scholar
• Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002; 10:153 - 169
   PubMed Web of Science ®Google Scholar
• Bowers AJ, Boylan JF. Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumors. Gene 2004; 328:135 - 142
   PubMed Web of Science ®Google Scholar
• Goetz SC, Anderson KV. The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet 2010; 11:331 - 344
   PubMed Web of Science ®Google Scholar
• Cervantes S, Lau J, Cano DA, Borromeo-Austin C, Hebrok M. Primary cilia regulate Gli/Hedgehog activation in pancreas. Proc Natl Acad Sci USA 2010; 107:10109 - 10114
   PubMed Web of Science ®Google Scholar
• Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 2007; 129:1351 - 1363
   PubMed Web of Science ®Google Scholar
• Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003; 9:991 - 997
   PubMed Web of Science ®Google Scholar
• Lim KH, Brady DC, Kashatus DF, Ancrile BB, Der CJ, Cox AD, et al. Aurora-A phosphorylates, activates and relocalizes the small GTPase RalA. Mol Cell Biol 2010; 30:508 - 523
   PubMed Web of Science ®Google Scholar
• Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N, et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005; 65:2899 - 2905
   PubMed Web of Science ®Google Scholar
• Seeley ES, Carriere C, Goetze T, Longnecker DS, Korc M. Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia. Cancer Res 2009; 69:422 - 430
   PubMed Web of Science ®Google Scholar
• Bailey JM, Mohr AM, Hollingsworth MA. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 2009; 28:3513 - 3525
   PubMed Web of Science ®Google Scholar
• Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009; 324:1457 - 1461
   PubMed Web of Science ®Google Scholar
• Lauth M, Bergström A, Shimokawa T, Tostar U, Jin Q, Fendrich V, et al. DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat Struct Mol Biol 2010; 17:718 - 725
   PubMed Web of Science ®Google Scholar
• Natoli TA, Gareski TC, Dackowski WR, Smith L, Bukanov NO, Russo RJ, et al. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures. Am J Physiol Renal Physiol 2008; 294:73 - 83
   Web of Science ®Google Scholar